FY2019 EPS Estimates for Healthequity Inc (HQY) Boosted by KeyCorp

Healthequity Inc (NASDAQ:HQY) – Analysts at KeyCorp increased their FY2019 earnings per share estimates for Healthequity in a note issued to investors on Tuesday. KeyCorp analyst D. Hooker now anticipates that the company will post earnings of $0.85 per share for the year, up from their previous estimate of $0.68.

Healthequity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, December 5th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.04. The firm had revenue of $56.80 million during the quarter, compared to the consensus estimate of $55.27 million. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The business’s revenue for the quarter was up 31.0% on a year-over-year basis. During the same period in the prior year, the business earned $0.10 EPS.

Other equities research analysts also recently issued reports about the company. Citigroup started coverage on Healthequity in a research note on Thursday, January 4th. They issued a “buy” rating for the company. Chardan Capital increased their price objective on Healthequity from $58.00 to $62.00 and gave the stock a “buy” rating in a research note on Wednesday, December 6th. Cantor Fitzgerald reissued a “buy” rating and issued a $56.00 price objective on shares of Healthequity in a research note on Tuesday, December 5th. Zacks Investment Research raised Healthequity from a “hold” rating to a “buy” rating and set a $60.00 price objective for the company in a research note on Wednesday, November 8th. Finally, BidaskClub raised Healthequity from a “sell” rating to a “hold” rating in a research note on Tuesday, November 7th. Two investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Healthequity has an average rating of “Buy” and an average price target of $56.67.

Shares of Healthequity (NASDAQ:HQY) traded up $0.30 during trading on Friday, reaching $51.29. The company had a trading volume of 465,541 shares, compared to its average volume of 472,066. The stock has a market cap of $3,130.00, a P/E ratio of 69.31, a P/E/G ratio of 1.89 and a beta of 1.70. Healthequity has a 1 year low of $37.62 and a 1 year high of $55.31.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Albion Financial Group UT increased its holdings in shares of Healthequity by 1.4% during the 2nd quarter. Albion Financial Group UT now owns 8,694 shares of the company’s stock valued at $433,000 after acquiring an additional 120 shares during the last quarter. Ameritas Investment Partners Inc. increased its holdings in shares of Healthequity by 17.4% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 4,375 shares of the company’s stock valued at $218,000 after acquiring an additional 648 shares during the last quarter. Advisory Services Network LLC increased its holdings in shares of Healthequity by 4.1% during the 4th quarter. Advisory Services Network LLC now owns 31,425 shares of the company’s stock valued at $1,466,000 after acquiring an additional 1,230 shares during the last quarter. Stifel Financial Corp increased its holdings in shares of Healthequity by 3.4% during the 2nd quarter. Stifel Financial Corp now owns 38,873 shares of the company’s stock valued at $1,916,000 after acquiring an additional 1,263 shares during the last quarter. Finally, UBS Asset Management Americas Inc. increased its holdings in shares of Healthequity by 4.3% during the 4th quarter. UBS Asset Management Americas Inc. now owns 32,586 shares of the company’s stock valued at $1,520,000 after acquiring an additional 1,348 shares during the last quarter. 98.20% of the stock is currently owned by institutional investors and hedge funds.

In other news, EVP Delano Ladd sold 26,405 shares of the stock in a transaction dated Tuesday, December 12th. The stock was sold at an average price of $43.32, for a total transaction of $1,143,864.60. Following the transaction, the executive vice president now owns 16,692 shares of the company’s stock, valued at approximately $723,097.44. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Frank Medici sold 700 shares of the stock in a transaction dated Wednesday, November 15th. The shares were sold at an average price of $51.05, for a total value of $35,735.00. Following the transaction, the director now directly owns 6,381 shares in the company, valued at approximately $325,750.05. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 371,426 shares of company stock worth $18,749,703. Insiders own 29.00% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This news story was originally published by Community Financial News and is owned by of Community Financial News. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://www.com-unik.info/2018/02/10/fy2019-eps-estimates-for-healthequity-inc-hqy-boosted-by-keycorp.html.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Earnings History and Estimates for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit